Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLAND PHARMA Plunges 4%; BSE HEALTHCARE Index Up 0.5%
Fri, 27 Sep 14:27

GLAND PHARMA Plunges 4%; BSE HEALTHCARE Index Up 0.5%Image source: Sefa Ozel/www.istockphoto.com

GLAND PHARMA share price has plunged 4% and is presently trading at Rs 1,779.8.

Meanwhile, the BSE HEALTHCARE index is at 44,348.6 (up 0.5%).

Among the top losers in the BSE HEALTHCARE index today are NARAYANA HRUDAYALAYA (down 2.3%) and HIKAL CHEMIC (down 1.8%).

Natco Pharma (up 2.7%) and Sun Pharma (up 2.4%) are among the top gainers today.

Over the last one year, GLAND PHARMA has moved up from Rs 1,659.7 to Rs 1,779.8, registering a gain of Rs 120.1 (up 7.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,800.9 to 44,348.6, registering a gain of 59.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 181.5%), SUVEN PHARMACEUTICALS (up 121.7%) and Glenmark Pharma (up 115.3%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 85,620.6 (down 0.3%).

The top losers among the BSE Sensex today are Power Grid Corp. (down 2.8%) and Bharti Airtel (down 2.4%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 26,185.8 (down 0.1%). Power Grid Corp. and Bharti Airtel are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.7 to 85,620.6, registering a gain of 19,596.9 points (up 29.7%).

GLAND PHARMA Financial Update...

GLAND PHARMA net profit fell 25.9% YoY to Rs 1,438 million for the quarter ended June 2024, compared to a profit of Rs 1,941 million a year ago. Net sales rose 16.0% to Rs 14,017 million during the period as against Rs 12,087 million in April-June 2023.

For the year ended March 2024, GLAND PHARMA reported 1.1% decrease in net profit to Rs 7,725 million compared to net profit of Rs 7,810 million during FY23. Revenue of the company grew 56.3% to Rs 56,647 million during FY24.

The current Price to earnings ratio of GLAND PHARMA, based on rolling 12 month earnings, stands at 40.6.


Equitymaster requests your view! Post a comment on "GLAND PHARMA Plunges 4%; BSE HEALTHCARE Index Up 0.5%". Click here!